Geode Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,670,247 shares of SWTX stock, worth $65.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,670,247

Previous 1,561,058 6.99%

Holding current value

$65.2 Million

Previous $58.8 Million 9.0%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.04 - $42.76 $3.5 Million - $4.67 Million	109,189 Added 6.99%	1,670,247 $53.5 Million
Q2 2024 Aug 09, 2024	BUY	$36.06 - $47.62 $2.03 Million - $2.68 Million	56,355 Added 3.75%	1,561,058 $58.8 Million
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $3.12 Million - $4.49 Million	85,615 Added 6.03%	1,504,703 $74.1 Million
Q4 2023 Feb 13, 2024	BUY	$18.94 - $37.24 $4.49 Million - $8.83 Million	236,978 Added 20.05%	1,419,088 $51.8 Million
Q3 2023 Nov 13, 2023	BUY	$23.12 - $31.38 $2.98 Million - $4.05 Million	128,944 Added 12.24%	1,182,110 $27.3 Million
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $5.2 Million - $7.35 Million	224,708 Added 27.12%	1,053,166 $27.6 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $716,114 - $976,519	28,679 Added 3.59%	828,458 $21.3 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $3.93 Million - $5.2 Million	180,885 Added 29.23%	799,779 $20.8 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $1.48 Million - $2.43 Million	61,230 Added 10.98%	618,894 $17.7 Million
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $814,376 - $2.66 Million	44,356 Added 8.64%	557,664 $13.7 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $1.03 Million - $1.37 Million	20,970 Added 4.26%	513,308 $29 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $261,276 - $371,767	4,902 Added 1.01%	492,338 $30.5 Million
Q3 2021 Nov 12, 2021	SELL	$62.66 - $88.26 $1.01 Million - $1.42 Million	-16,133 Reduced 3.2%	487,436 $30.9 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $3.74 Million - $4.75 Million	55,435 Added 12.37%	503,569 $41.5 Million
Q1 2021 May 12, 2021	BUY	$65.1 - $93.59 $2.76 Million - $3.96 Million	42,323 Added 10.43%	448,134 $33 Million
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $3.29 Million - $5.29 Million	67,937 Added 20.11%	405,811 $29.4 Million
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $3.64 Million - $5.23 Million	100,650 Added 42.43%	337,874 $16.1 Million
Q2 2020 Aug 13, 2020	BUY	$22.98 - $48.57 $1.76 Million - $3.72 Million	76,611 Added 47.7%	237,224 $9.96 Million
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $593,087 - $1.2 Million	29,016 Added 22.05%	160,613 $4.34 Million
Q4 2019 Feb 13, 2020	BUY	$17.74 - $39.52 $2.33 Million - $5.2 Million	131,597 New	131,597 $5.07 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History